- Favorable safety profile of ixekizumab: results from 11 moderate-to-s…
Number of the records: 1  

Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials

  1. SYS0148398
    LBL
      
    00000naa--2200000-a-4500
    005
      
    20250607164734.8
    008
      
    180806s2018----xo-----e------------eng--
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng
    044
      
    $a xo $c SK
    245
    10
    $a Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials / $c Alice Gottlieb ... [et al.]
    700
    1-
    $7 sllk_us_auth*0046922 $a Gottlieb, Alice $4 aut
    711
    2-
    $7 sllk_us_auth*0046479 $a Kongres slovenských a českých dermatovenerológov s medzinárodnou účasťou $n (14. : $d 2018 : $c Jasná, Demänovská Dolina, Slovensko)
    773
    0-
    $7 nnam $w sllk_us_cat*0146987 $t <XIV.> kongres slovenských a českých dermatovenerológov s medzinárodnou účasťou $d [S.l. : s.n., 2018] $g S. 19-20
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.